Liver Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with hepatocellular carcinoma (a type of liver cancer)
- People whose liver cancer diagnosis was made following recognised international guidelines for liver cancer management
- People who have at least one tumour that is large enough to be measured using standard medical imaging criteria
- People who are expected to live for at least 12 weeks or more
- People who are willing and able to sign a consent form and attend the required study visits and follow the study procedures
Who may not be able to join:
- People who have another active cancer or serious medical complications alongside their liver cancer
- People whose tumour tissue sample is not large enough or suitable enough to be used for a specific type of cancer testing required by the trial (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Ze-yang Ding, M.D., Tongji Hospital
Phone: +8613407156200
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Progression-Free Survival (PFS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.